Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology

Journal of the American College of Cardiology

Volumn 66, Issue 21, 2015, Pages 2362-2371

  Maron, Barry J ^a   Udelson, James E ^a   Bonow, Robert O ^a   Nishimura, Rick A ^a   Ackerman, Michael J ^a   Estes, N A Mark ^a   Cooper, Leslie T ^a   Link, Mark S ^a   Maron, Martin S ^a  

^a NONE

Author keywords

ACC AHA Scientific Statements; arrhythmogenic right ventricular cardiomyopathy; athletes; cardiomyopathy; cardiovascular abnormalities; cardiovascular magnetic resonance; hypertrophic cardiomyopathy; myocarditis; sudden death

Indexed keywords

ARTICLE; ATHLETE; ATRIAL FIBRILLATION; CARDIOMYOPATHY; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MALFORMATION; CONGESTIVE CARDIOMYOPATHY; ENDURANCE TRAINING; EXERCISE INTENSITY; EXERCISE TEST; FAINTNESS; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MYOCARDITIS; NONHUMAN; PERICARDITIS; PRIMARY PREVENTION; PRIORITY JOURNAL; RETURN TO SPORT; SPORTS AND SPORT RELATED PHENOMENA; SPORTS PARTICIPATION; SUDDEN DEATH; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ADOLESCENT; ADULT; ADVISORY COMMITTEE; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIOLOGY; CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOVASCULAR ABNORMALITIES; CHILD; COMPLICATION; FEMALE; MALE; MEDICAL SOCIETY; PRACTICE GUIDELINE; STANDARDS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; ADVISORY COMMITTEES; AMERICAN HEART ASSOCIATION; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ATHLETES; CARDIOLOGY; CARDIOMYOPATHIES; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOVASCULAR ABNORMALITIES; CHILD; FEMALE; HUMANS; MALE; MYOCARDITIS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES; YOUNG ADULT;

EID: 84961056921     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.09.035     Document Type: Article

References (64)

1. B.J. Maron, and M.S. Maron Hypertrophic cardiomyopathy Lancet 381 2013 242 255 http://dx.doi.org/10.1016/S0140-6736(12)60397-3
2. B.J. Maron, S.R. Ommen, C. Semsarian, P. Spirito, I. Olivotto, and M.S. Maron Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine [published correction appears in J Am Coll Cardiol. 2014;64:1188] J Am Coll Cardiol 64 2014 83 99 http://dx.doi.org/10.1016/j.jacc.2014.05.003
3. B.J. Maron, J.J. Doerer, T.S. Haas, D.M. Tierney, and F.O. Mueller Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006 Circulation 119 2009 1085 1092 http://dx.doi.org/10.1161/CIRCULATIONAHA.108.804617
4. B.J. Maron, J.M. Gardin, J.M. Flack, S.S. Gidding, T.T. Kurosaki, and D.E. Bild Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA Study: Coronary Artery Risk Development in (Young) Adults Circulation 92 1995 785 789
5. B.J. Maron, M.S. Maron, and C. Semsarian Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives J Am Coll Cardiol 60 2012 705 715 http://dx.doi.org/10.1016/j.jacc.2012.02.068
6. M.S. Maron, B.J. Maron, C. Harrigan, J. Buros, C.M. Gibson, I. Olivotto, L. Biller, J.R. Lesser, J.E. Udelson, W.J. Manning, and E. Appelbaum Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228 http://dx.doi.org/10.1016/j.jacc.2009.05.006
7. B.J. Maron, E.J. Rowin, S.A. Casey, M.S. Link, J.R. Lesser, R.H. Chan, R.F. Garberich, J.E. Udelson, and M.S. Maron Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies J Am Coll Cardiol 65 2015 1915 1928 http://dx.doi.org/10.1016/j.jacc.2015.02.061
8. B.J. Maron, P. Spirito, W.K. Shen, T.S. Haas, F. Formisano, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, T. Lawrenz, G. Boriani, N.A. Estes 3rd, S. Favale, M. Piccininno, S.L. Winters, M. Santini, S. Betocchi, F. Arribas, M.V. Sherrid, G. Buja, C. Semsarian, and P. Bruzzi Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy [published correction appears in JAMA. 2007;298:1516] JAMA 298 2007 405 412 http://dx.doi.org/10.1001/jama.298.4.405
9. A.F. Schinkel, P.A. Vriesendorp, E.J. Sijbrands, L.J. Jordaens, F.J. ten Cate, and M. Michels Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy: systematic review and meta-analysis Circ Heart Fail 5 2012 552 559 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.112.969626
10. B.J. Maron, P. Spirito, M.J. Ackerman, S.A. Casey, C. Semsarian, N.A. Estes 3rd, K.M. Shannon, E.A. Ashley, S.M. Day, G. Pacileo, F. Formisano, E. Devoto, A. Anastasakis, J.M. Bos, A. Woo, C. Autore, R.H. Pass, G. Boriani, R.F. Garberich, A.K. Almquist, M.W. Russell, L. Boni, S. Berger, M.S. Maron, and M.S. Link Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy J Am Coll Cardiol 61 2013 1527 1535 http://dx.doi.org/10.1016/j.jacc.2013.01.037
11. B.J. Maron, M.J. Ackerman, R.A. Nishimura, R.E. Pyeritz, J.A. Towbin, and J.E. Udelson Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis and Marfan syndrome J Am Coll Cardiol 45 2005 1340 1345
12. B.J. Gersh, B.J. Maron, R.O. Bonow, J.A. Dearani, M.A. Fifer, M.S. Link, S.S. Naidu, R.A. Nishimura, S.R. Ommen, H. Rakowski, C.E. Seidman, J.A. Towbin, J.E. Udelson, and C.W. Yancy 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 58 2011 2703 2738 http://dx.doi.org/10.1016/j.jacc.2011.10.825
13. B.J. Maron, L. Yeates, and C. Semsarian Clinical challenges of genotype positive (+)-phenotype negative (-) family members in hypertrophic cardiomyopathy Am J Cardiol 107 2011 604 608 http://dx.doi.org/10.1016/j.amjcard.2010.10.022
14. B.J. Maron, H. Niimura, S.A. Casey, M.K. Soper, G.B. Wright, J.G. Seidman, and C.E. Seidman Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations J Am Coll Cardiol 38 2001 315 321
15. B.J. Maron, T.S. Haas, C. Kitner, and J.R. Lesser Onset of apical hypertrophic cardiomyopathy in adulthood Am J Cardiol 108 2011 1783 1787 http://dx.doi.org/10.1016/j.amjcard.2011.07.048
16. C.Y. Ho, N.K. Sweitzer, B. McDonough, B.J. Maron, S.A. Casey, J.G. Seidman, C.E. Seidman, and S.D. Solomon Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy Circulation 105 2002 2992 2997
17. M.S. Maron, E.J. Rowin, D. Lin, E. Appelbaum, R.H. Chan, C.M. Gibson, J.R. Lesser, J. Lindberg, T.S. Haas, J.E. Udelson, W.J. Manning, and B.J. Maron Prevalence and clinical profile of myocardial crypts in hypertrophic cardiomyopathy Circ Cardiovasc Imaging 5 2012 441 447 http://dx.doi.org/10.1161/CIRCIMAGING.112.972760
18. E.J. Rowin, M.S. Maron, J.R. Lesser, and B.J. Maron CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy J Am Coll Cardiol Img 5 2012 119 122 http://dx.doi.org/10.1016/j.jcmg.2011.08.020
19. M.S. Maron, I. Olivotto, C. Harrigan, E. Appelbaum, C.M. Gibson, J.R. Lesser, T.S. Haas, J.E. Udelson, W.J. Manning, and B.J. Maron Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy Circulation 124 2011 40 47 http://dx.doi.org/10.1161/CIRCULATIONAHA.110.985812
20. I. Christiaans, R.H. Lekanne dit Deprez, I.M. van Langen, and A.A. Wilde Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy Heart Rhythm 6 2009 1366 1369 http://dx.doi.org/10.1016/j.hrthm.2009.04.029
21. C. Rickers, N.M. Wilke, M. Jerosch-Herold, S.A. Casey, P. Panse, N. Panse, J. Weil, A.G. Zenovich, and B.J. Maron Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 2005 855 861 http://dx.doi.org/10.1161/CIRCULATIONAHA.104.507723
22. B.D. Levine, A.L. Baggish, R.J. Kovacs, M.S. Link, M.S. Maron, J.H. Mitchell on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing Council on Functional Genomics and Translational Biology, and the American College of Cardiology Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 1: classification of sport: dynamic, static, and impact: a scientific statement from the American Heart Association and American College of Cardiology J Am Coll Cardiol 66 2015 2350 2355
23. D.P. Zipes, M.S. Link, M.J. Ackerman, R.J. Kovacs, R.J. Myerburg, N.A.M. Estes 3rd on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing Council on Functional Genomics and Translational Biology, and the American College of Cardiology Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 9: arrhythmias and conduction defects: a scientific statement from the American Heart Association and American College of Cardiology J Am Coll Cardiol 66 2015 2412 2423
24. B.J. Maron, J.A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett, A.J. Moss, C.E. Seidman, and J.B. Young Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention Circulation 113 2006 1807 1816 http://dx.doi.org/10.1161/CIRCULATIONAHA.106.174287
25. R.B. Stacey, M. Andersen, J. Haag, M.E. Hall, G. McLeod, B. Upadhya, W.G. Hundley, and V. Thohan Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy Am J Cardiol 113 2014 1018 1023 http://dx.doi.org/10.1016/j.amjcard.2013.12.008
26. E.N. Oechslin, C.H. Attenhofer Jost, J.R. Rojas, P.A. Kaufmann, and R. Jenni Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis J Am Coll Cardiol 36 2000 493 500
27. S. Klaassen, S. Probst, E. Oechslin, B. Gerull, G. Krings, P. Schuler, M. Greutmann, D. Hürlimann, M. Yegitbasi, L. Pons, M. Gramlich, J.D. Drenckhahn, A. Heuser, F. Berger, R. Jenni, and L. Thierfelder Mutations in sarcomere protein genes in left ventricular noncompaction Circulation 117 2008 2893 2901 http://dx.doi.org/10.1161/CIRCULATIONAHA.107.746164
28. S. Gati, N. Chandra, R.L. Bennett, M. Reed, G. Kervio, V.F. Panoulas, S. Ghani, N. Sheikh, A. Zaidi, M. Wilson, M. Wilson, M. Papadakis, F. Carré, and S. Sharma Increased left ventricular trabeculation in highly trained athletes: do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes [published correction appears in Heart. 2013;99:506]? Heart 99 2013 401 408 http://dx.doi.org/10.1136/heartjnl-2012-303418
29. H.V. Ganga, and P.D. Thompson Sports participation in non-compaction cardiomyopathy: a systematic review Br J Sports Med 48 2014 1466 1471 http://dx.doi.org/10.1136/bjsports-2012-091855
30. P. Thavendiranathan, A. Dahiya, D. Phelan, M.Y. Desai, and W.H. Tang Isolated left ventricular non-compaction controversies in diagnostic criteria, adverse outcomes and management Heart 99 2013 681 689 http://dx.doi.org/10.1136/heartjnl-2012-302816
31. K. Caliskan, M. Michels, M.L. Geleijnse, R.T. van Domburg, R. van der Boon, A.H. Balk, and M.L. Simoons Frequency of asymptomatic disease among family members with noncompaction cardiomyopathy Am J Cardiol 110 2012 1512 1517 http://dx.doi.org/10.1016/j.amjcard.2012.07.009
32. A. Kelley-Hedgepeth, J.A. Towbin, and M.S. Maron Images in cardiovascular medicine: overlapping phenotypes: left ventricular noncompaction and hypertrophic cardiomyopathy Circulation 119 2009 e588 e589 http://dx.doi.org/10.1161/CIRCULATIONAHA.108.829564
33. M. Greutmann, M.L. Mah, C.K. Silversides, S. Klaassen, C.H. Attenhofer Jost, R. Jenni, and E.N. Oechslin Predictors of adverse outcome in adolescents and adults with isolated left ventricular noncompaction Am J Cardiol 109 2012 276 281 http://dx.doi.org/10.1016/j.amjcard.2011.08.043
34. S.T. Brescia, J.W. Rossano, R. Pignatelli, J.L. Jefferies, J.F. Price, J.A. Decker, S.W. Denfield, W.J. Dreyer, O. Smith, J.A. Towbin, and J.J. Kim Mortality and sudden death in pediatric left ventricular noncompaction in a tertiary referral center Circulation 127 2013 2202 2208 http://dx.doi.org/10.1161/CIRCULATIONAHA.113.002511
35. T.E. Paterick, and A.J. Tajik Left ventricular noncompaction: a diagnostically challenging cardiomyopathy Circ J 76 2012 1556 1562
36. R. Jenni, E. Oechslin, J. Schneider, C. Attenhofer Jost, and P.A. Kaufmann Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy Heart 86 2001 666 671
37. A. Pelliccia, F. Culasso, F.M. Di Paolo, and B.J. Maron Physiologic left ventricular cavity dilatation in elite athletes Ann Intern Med 130 1999 23 31
38. A. Pelliccia, B.J. Maron, F. Culasso, A. Spataro, and G. Caselli Athlete's heart in women: echocardiographic characterization of highly trained elite female athletes JAMA 276 1996 211 215
39. J. Karjalainen, and J. Heikkilä Incidence of three presentations of acute myocarditis in young men in military service: a 20-year experience Eur Heart J 20 1999 1120 1125 http://dx.doi.org/10.1053/euhj.1998.1444
40. M.A. Weber, M.T. Ashworth, R.A. Risdon, M. Malone, M. Burch, and N.J. Sebire Clinicopathological features of paediatric deaths due to myocarditis: an autopsy series Arch Dis Child 93 2008 594 598 http://dx.doi.org/10.1136/adc.2007.128686
41. B. Morentin, M.P. Suárez-Mier, B. Aguilera, and A. Bodegas Myocardial disease mortality in children and young adults: a population-based observational study [in Spanish] Rev Esp Cardiol 59 2006 238 246
42. I.D. Kitulwatte, P.J. Kim, and M.S. Pollanen Sudden death related myocarditis: a study of 56 cases Forensic Sci Med Pathol 6 2010 13 19 http://dx.doi.org/10.1007/s12024-009-9125-5
43. D. Corrado, C. Basso, and G. Thiene Sudden cardiac death in young people with apparently normal heart Cardiovasc Res 50 2001 399 408
44. M. Phillips, M. Robinowitz, J.R. Higgins, K.J. Boran, T. Reed, and R. Virmani Sudden cardiac death in Air Force recruits: a 20-year review JAMA 256 1986 2696 2699
45. R.J. Kiel, F.E. Smith, J. Chason, R. Khatib, and M.P. Reyes Coxsackievirus B3 myocarditis in C3H/HeJ mice: description of an inbred model and the effect of exercise on virulence Eur J Epidemiol 5 1989 348 350
46. J.D. Hosenpud, S.M. Campbell, N.R. Niles, J. Lee, D. Mendelson, and M.V. Hart Exercise induced augmentation of cellular and humoral autoimmunity associated with increased cardiac dilatation in experimental autoimmune myocarditis Cardiovasc Res 21 1987 217 222
47. S. Machado, F. Roubille, G. Gahide, H. Vernhet-Kovacsik, L. Cornillet, T.T. Cung, C. Sportouch-Dukhan, F. Raczka, J.L. Pasquié, R. Gervasoni, J.C. Macia, F. Cransac, J.M. Davy, C. Piot, and F. Leclercq Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris) 59 2010 1 7 http://dx.doi.org/10.1016/j.ancard.2009.07.009
48. M. Imazio, and L.T. Cooper Management of myopericarditis Expert Rev Cardiovasc Ther 11 2013 193 201 http://dx.doi.org/10.1586/erc.12.184
49. M. Imazio, A. Brucato, A. Barbieri, F. Ferroni, S. Maestroni, G. Ligabue, A. Chinaglia, D. Cumetti, G. Della Casa, F. Bonomi, F. Mantovani, P. Di Corato, R. Lugli, R. Faletti, S. Leuzzi, R. Bonamini, M.G. Modena, and R. Belli Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study Circulation 128 2013 42 49 http://dx.doi.org/10.1161/CIRCULATIONAHA.113.001531
50. L.T. Cooper Jr. Myocarditis N Engl J Med 360 2009 1526 1538 http://dx.doi.org/10.1056/NEJMra0800028
51. M.G. Friedrich, U. Sechtem, J. Schulz-Menger, G. Holmvang, P. Alakija, L.T. Cooper, J.A. White, H. Abdel-Aty, M. Gutberlet, S. Prasad, A. Aletras, J.P. Laissy, I. Paterson, N.G. Filipchuk, A. Kumar, M. Pauschinger, P. Liu International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis Cardiovascular magnetic resonance in myocarditis: a JACC White Paper J Am Coll Cardiol 53 2009 1475 1487 http://dx.doi.org/10.1016/j.jacc.2009.02.007
52. S. Grün, J. Schumm, S. Greulich, A. Wagner, S. Schneider, O. Bruder, E.M. Kispert, S. Hill, P. Ong, K. Klingel, R. Kandolf, U. Sechtem, and H. Mahrholdt Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery J Am Coll Cardiol 59 2012 1604 1615 http://dx.doi.org/10.1016/j.jacc.2012.01.007
53. L.T. Cooper, K.L. Baughman, A.M. Feldman, A. Frustaci, M. Jessup, U. Kuhl, G.N. Levine, J. Narula, R.C. Starling, J. Towbin, and R. Virmani The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Circulation 116 2007 2216 2233 http://dx.doi.org/10.1161/CIRCULATIONAHA.107.186093
54. D. Corrado, C. Basso, A. Pavei, P. Michieli, M. Schiavon, and G. Thiene Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program JAMA 296 2006 1593 1601 http://dx.doi.org/10.1001/jama.296.13.1593
55. C. Basso, D. Corrado, F.I. Marcus, A. Nava, and G. Thiene Arrhythmogenic right ventricular cardiomyopathy Lancet 373 2009 1289 1300 http://dx.doi.org/10.1016/S0140-6736(09)60256-7
56. D. Corrado, and G. Thiene Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies Circulation 113 2006 1634 1637 http://dx.doi.org/10.1161/CIRCULATIONAHA.105.616490
57. S. Sen-Chowdhry, P. Syrris, and W.J. McKenna Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 50 2007 1813 1821 http://dx.doi.org/10.1016/j.jacc.2007.08.008
58. F.I. Marcus, W.J. McKenna, D. Sherrill, C. Basso, B. Bauce, D.A. Bluemke, H. Calkins, D. Corrado, M.G. Cox, J.P. Daubert, G. Fontaine, K. Gear, R. Hauer, A. Nava, M.H. Picard, N. Protonotarios, J.E. Saffitz, D.M. Sanborn, J.S. Steinberg, H. Tandri, G. Thiene, J.A. Towbin, A. Tsatsopoulou, T. Wichter, and W. Zareba Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria Eur Heart J 31 2010 806 814 http://dx.doi.org/10.1093/eurheartj/ehq025
59. P. Kirchhof, L. Fabritz, M. Zwiener, H. Witt, M. Schäfers, S. Zellerhoff, M. Paul, T. Athai, K.H. Hiller, H.A. Baba, G. Breithardt, P. Ruiz, T. Wichter, and B. Levkau Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice Circulation 114 2006 1799 1806 http://dx.doi.org/10.1161/CIRCULATIONAHA.106.624502
60. C.A. James, A. Bhonsale, C. Tichnell, B. Murray, S.D. Russell, H. Tandri, R.J. Tedford, D.P. Judge, and H. Calkins Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers J Am Coll Cardiol 62 2013 1290 1297 http://dx.doi.org/10.1016/j.jacc.2013.06.033
61. G. Thiene, A. Nava, D. Corrado, L. Rossi, and N. Pennelli Right ventricular cardiomyopathy and sudden death in young people N Engl J Med 318 1988 129 133 http://dx.doi.org/10.1056/NEJM198801213180301
62. D. Corrado, L. Leoni, M.S. Link, P. Della Bella, F. Gaita, A. Curnis, J.U. Salerno, D. Igidbashian, A. Raviele, M. Disertori, G. Zanotto, R. Verlato, G. Vergara, P. Delise, P. Turrini, C. Basso, F. Naccarella, F. Maddalena, N.A. Estes 3rd, G. Buja, and G. Thiene Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia Circulation 108 2003 3084 3091 http://dx.doi.org/10.1161/01.CIR.0000103130.33451.D2
63. T. Wichter, M. Paul, C. Wollmann, T. Acil, P. Gerdes, O. Ashraf, T.D. Tjan, R. Soeparwata, M. Block, M. Borggrefe, H.H. Scheld, G. Breithardt, and D. Böcker Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients Circulation 109 2004 1503 1508 http://dx.doi.org/10.1161/01.CIR.0000121738.88273.43
64. D. Corrado, H. Calkins, M.S. Link, L. Leoni, S. Favale, M. Bevilacqua, C. Basso, D. Ward, G. Boriani, R. Ricci, J.P. Piccini, D. Dalal, M. Santini, G. Buja, S. Iliceto, N.A. Estes 3rd, T. Wichter, W.J. McKenna, G. Thiene, and F.I. Marcus Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia Circulation 122 2010 1144 1152 http://dx.doi.org/10.1161/CIRCULATIONAHA.109.913871